期刊文献+

左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床研究 被引量:4

Clinical investigation on the effect of levonorgestrel-releasing intrauterine system on adenomyosis
原文传递
导出
摘要 目的:探讨左炔诺孕酮宫内缓释系统LNG-IUS治疗子宫腺肌病的临床疗效。方法:选择94例子宫腺肌病患者宫内放置LNG-IUS,观察其放置前后月经量、痛经程度、血红蛋白水平及子宫体积变化。结果:放置LNG-IUS1个月后月经量减少至放置前的(32±11)%,3月后减少至放置前的(24±8)%,12个月后减少至放置前的(6±3)%,各月月经量放置前后比较差异有统计学意义(P<0.01);子宫体积在治疗后与治疗前比较,差异无统计学意义(P>0.05);患者痛经症状显著缓解或完全消失;37例贫血患者血红蛋白水平从治疗前的(89±12)g/L恢复至治疗后的(126±10)g/L。结论:LNG-IUS治疗子宫腺肌病有较好的疗效。 Objective: To explore the clinical efficacy of levonorgestrel -releasing intrauterine system (LNG -IUS) in the treatment of adenomyosis. Methods: 94 cases with adenomyosis were treated with LNG - IUS, and the menstrual blood volume, degree of dysmenorrheal, hemoglobin level and uterine volume were observed. Results: After one month, 3 months and 12 months, the menstrual blood volume reduced to ( 32 ± 11 ) %, (24 ± 8 ) % and ( 6 ± 3 ) % of those before treatment, respectively, there was significant difference in menstrual blood volume before and after the treatment (P 〈 0. 01 ) ; there was no signifieant difference in uterine volume before and after the treatment ( P 〉 0. 05 ) ; dysmenorrheal relieved obviously or completely ; hemoglobin level recovered from ( 89 ± 12) g/L to ( 126 ± 10 ) g/L in 37 patients with anemia. Conclusion : LNG - IUS is an effective method in the treatment of adenomyosis.
出处 《中国妇幼保健》 CAS 北大核心 2009年第25期3504-3506,共3页 Maternal and Child Health Care of China
关键词 子宫腺肌病左炔诺孕酮 药物释放系统月经量痛经 Adenomyosis Levonorgestrel Drug releasing system Menstrual blood volume Dysmenorrhea
  • 相关文献

参考文献7

二级参考文献33

共引文献382

同被引文献24

  • 1何淑明,韦明秀,韩燕华,何立红.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].中华妇产科杂志,2005,40(8):536-538. 被引量:115
  • 2邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量:113
  • 3魏丽娜,祁秀娟,赵文翠,段玉英,吕映频.左炔诺孕酮宫内缓释系统治疗子宫腺肌病疗效观察[J].中国实用妇科与产科杂志,2007,23(3):192-194. 被引量:48
  • 4乐杰.妇产科学[M].7版.北京:人民卫生出版社,2006:205.
  • 5Higham JM, Obrien PM, Shaw RW. Assessment of menstrual blood loss using a pictoral chart [J]. Br J Obstet Gynaecol, 1990; 97 ( 8 ) : 734-739.
  • 6Vereide AB, Kaino T, Sager G, et al.Effect of lev- onorgestrel IUD and oral medroxypmgesteron eac- etate on glandular and stromalprogesterone receptors ( PRA and PRB) , and estrogen receptors ( ER al- pha and ER beta) in human endometrial hyperpla- sia. Gynecol Oncol,2006; 101(2):214-222.
  • 7Jim 6 nez MF, Arbo E, Vetori D, et al. The effect of the levonorgestrel-releasing intrauterine system and the copper intrauterine deyice on subendometrial microvascularization and uterine artery blood flow [J]. Fertil Steril, 2008 ;90(5) : 1574-1578.
  • 8Lete I, Crist 6 hal I, Febrer L, et al. Economic eval- uation of the levonorgestrel-releasing intrauterinesystem for the treatment of dysfunctional uterine bleeding in Spain [J]. Eur J Obstet Gynecol Reprod Biol, 2011 ; 154( 1 ) :71-80.
  • 9谢幸,苟文丽,等.妇产科学[M].第8版,人民卫生出版社,2013,3:75.
  • 10Jim6nez MF,Arbo E,Vetori D.The effect of the levonorgestrel -releasing intrauterine system and the copper intrauterine device on subendometrial mlcrovascularizatlon and uterine artery blood flow [J]. Fertility and Sterility,2008,90(5):1574-1578.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部